We are live on ! Find out more
GPP

Great Point Partners Portfolio holdings

AUM $408M
1-Year Est. Return 318.81%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+318.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$408M
AUM Growth
+$99.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1 +$21.4M
2 +$19.8M
3 +$17.7M
4
ANNX icon
Annexon
ANNX
+$14.1M
5
ZBIO
Zenas BioPharma
ZBIO
+$11.8M

Top Sells

1 +$19.9M
2 +$19.7M
3 +$18.5M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$14.4M
5
FULC icon
Fulcrum Therapeutics
FULC
+$9.05M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
1
Apogee Therapeutics
APGE
$6.75B
$31.5M 7.71%
374,000
VOR icon
2
Vor Biopharma
VOR
$763M
$31.2M 7.65%
1,750,000
+379,893
ZURA icon
3
Zura Bio
ZURA
$340M
$25.1M 6.14%
4,215,930
+400,000
AMLX icon
4
Amylyx Pharmaceuticals
AMLX
$1.55B
$24.3M 5.96%
1,750,000
NKTR icon
5
Nektar Therapeutics
NKTR
$2B
$22.8M 5.58%
316,453
+105,721
SLGL icon
6
Sol-Gel Technologies
SLGL
$246M
$21.7M 5.32%
+274,363
ALMS
7
Alumis Inc
ALMS
$2.66B
$18.9M 4.62%
+856,061
DRUG
8
Bright Minds Biosciences
DRUG
$604M
$16.1M 3.93%
+220,000
ANNX icon
9
Annexon
ANNX
$770M
$13.8M 3.39%
+2,500,000
KALV icon
10
KalVista Pharmaceuticals
KALV
$1.44B
$13.6M 3.33%
675,000
-10,632
IMVT icon
11
Immunovant
IMVT
$6.75B
$13.6M 3.32%
545,625
-204,375
JBIO
12
Jade Biosciences
JBIO
$979M
$13.6M 3.32%
964,462
+158,189
CTNM
13
Contineum Therapeutics
CTNM
$443M
$10.5M 2.56%
800,198
+198
ZBIO
14
Zenas BioPharma
ZBIO
$1.12B
$10.2M 2.51%
+524,066
NGNE icon
15
Neurogene
NGNE
$458M
$10.1M 2.47%
500,000
+150,000
MLTX icon
16
MoonLake Immunotherapeutics
MLTX
$1.31B
$9.32M 2.28%
+500,000
CLYM
17
Climb Bio
CLYM
$625M
$9.14M 2.24%
1,334,130
+354,596
ORKA
18
Oruka Therapeutics
ORKA
$4.13B
$8.99M 2.2%
183,330
EPRX
19
Eupraxia Pharmaceuticals
EPRX
$394M
$8.69M 2.13%
1,200,000
VERA icon
20
Vera Therapeutics
VERA
$2.42B
$8.02M 1.96%
+199,348
EVMN
21
Evommune Inc
EVMN
$745M
$7.47M 1.83%
325,000
LBRX
22
LB Pharmaceuticals
LBRX
$818M
$7.4M 1.81%
+300,000
CMPX icon
23
Compass Therapeutics
CMPX
$362M
$7.14M 1.75%
+1,350,000
SCYX icon
24
SCYNEXIS
SCYX
$42.2M
$6.93M 1.7%
+7,554,347
PALI icon
25
Palisade Bio
PALI
$309M
$5.96M 1.46%
+3,405,757